AR and Familial prostate cancer: One possibility is that prostate cancer cells achieve this by adapting their AR pathway to the low androgen/high antiandrogen levels, for example by mutation, amplification or truncation to a constitutively active AR, deregulation of AR cofactors and/or intratumoral androgen production [6], [7].